Afya Non-GAAP EPS of R$2.27, revenue of R$919.4M; reaffirms FY outlook

* Afya press release [https://seekingalpha.com/pr/20200396-afya-limited-announces-second-quarter-and-first-half-2025-financial-results] (NASDAQ:AFYA [https://seekingalpha.com/symbol/AFYA]): Q2 Non-GAAP EPS of R$2.27.
* Revenue of R$919.4M (+13.5% Y/Y).
* 2Q25 Adjusted EBITDA increased 16.6% YoY reaching R$400.8 million, with an Adjusted EBITDA Margin of 43.6%.
* Operating Cash Conversion ratio of 88.8%, with a solid cash position of R$ 1,099.1 million.
*
2025 GUIDANCE

THE COMPANY IS REAFFIRMING ITS GUIDANCE FOR 2025, AS DEFINED IN THE FOLLOWING TABLE, WHICH CONSIDERS THE SUCCESSFUL ACCEPTANCE OF NEW STUDENTS FOR THE SECOND SEMESTER OF 2025:

Guidance for 2025

Revenue

R$ 3,670 mn ≤ ∆ ≤ R$ 3,770 mn

Adjusted EBITDA

R$ 1,620 mn ≤ ∆ ≤ R$ 1,720 mn

CAPEX 1

R$ 250 mn ≤ ∆ ≤ R$ 290 mn

(1) Excludes the license CAPEX related to the acquisition of FUNIC.

MORE ON AFYA

* Afya Limited 2025 Q2 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4813423-afya-limited-2025-q2-results-earnings-call-presentation]
* Afya Limited (AFYA) Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4813422-afya-limited-afya-q2-2025-earnings-call-transcript]
* Afya Limited Continues To Grow, But Limits Are Also Evident [https://seekingalpha.com/article/4788707-afya-continues-to-grow-but-limits-are-also-evident]
* Seeking Alpha’s Quant Rating on Afya [https://seekingalpha.com/symbol/AFYA/ratings/quant-ratings]
* Historical earnings data for Afya [https://seekingalpha.com/symbol/AFYA/earnings]